0001209191-16-141402.txt : 20160914
0001209191-16-141402.hdr.sgml : 20160914
20160914162048
ACCESSION NUMBER: 0001209191-16-141402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160913
FILED AS OF DATE: 20160914
DATE AS OF CHANGE: 20160914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flexion Therapeutics Inc
CENTRAL INDEX KEY: 0001419600
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 305-7777
MAIL ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stejbach Mark
CENTRAL INDEX KEY: 0001487937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36287
FILM NUMBER: 161885291
MAIL ADDRESS:
STREET 1: C/O TENGION, INC.
STREET 2: 2900 POTSHOP LANE, SUITE 100
CITY: EAST NORRITON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-13
0
0001419600
Flexion Therapeutics Inc
FLXN
0001487937
Stejbach Mark
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
1
0
0
0
Stock Option (right to buy)
15.87
2016-09-13
4
A
0
25000
0.00
A
2026-09-12
Common Stock
25000
25000
D
One-third of the shares subject to the option will vest on September 13, 2017 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter.
/s/ Jonathan H. Mahlowitz, Attorney-in-Fact
2016-09-14